GMK LABS

Research and development in pharmaceuticals, including marketing of bulk drugs and intermediates.

About GMK LABS

GMK LABS is a Healthcare company. Research and development in pharmaceuticals, including marketing of bulk drugs and intermediates. The company has 35 employees. Its Indian entity Gmk Labs Private Limited reported revenue of β‚Ή20.38 Cr. GMK LABS offers products and services including Bulk Drugs and Research Services. Its focus areas include Healthcare and Pharmaceuticals, Industrial Supplies, Chemical Production and Drug Intermediates.

Company details

GMK LABS Private Limited is noted for its dedication to excellence in the pharmaceutical industry, having been incorporated in 2006 to advance research and development of bulk drugs and intermediates. A culture of continuous learning and innovation is maintained, with processes and technologies regularly improved to stay ahead. Client needs are addressed through collaborative, tailored solutions that emphasize quality and trust, while customer and worker care is prioritized. This approach ensures high-quality products and long-term success are achieved in a fast-paced environment.

Key Metrics
  • Indian entity revenue
    ₹20.38 Cr

    FY 2025 · -34% YoY

  • Indian entity net profit
    ₹48.2 Lakh

    FY 2025 · 2% margin

  • Indian entity EBITDA
    ₹1.39 Cr

    FY 2025 · 7% margin

  • Employee Count
    35

Products & Services of GMK LABS

GMK LABS offers a comprehensive portfolio of products and services, including Bulk Drugs and Research Services.

Bulk Drugs
Pharmaceutical Products

Bulk drugs and intermediates are developed and marketed by GMK LABS to support pharmaceutical production and innovation.

Research Services
Development Services

Research and development services are provided by GMK LABS, focusing on exploring new ideas and improving processes in the pharmaceutical field.

Board of directors of Gmk Labs Private Limited (GMK LABS)

Gmk Labs Private Limited is the primary company behind GMK LABS. The board of Gmk Labs Private Limited currently have 3 directors; the longest-serving is Murali Krishna Gollapudi, appointed in 2006. 5 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Murali Krishna Gollapudi
DIN 00040336
Managing Director07 Nov 200619 yrs 11 moGmk Labs Private Limited
Nirmala Gollapudi
DIN 01712979
Director07 Nov 200619 yrs 11 moGmk Labs Private Limited
Gollapudi Sri Shanmukha Sri Krishna Chaitanya
DIN 10157078
Director14 May 20233 yrs 5 moGmk Labs Private Limited

Financials of GMK LABS

Figures of Gmk Labs Private Limited, the primary company behind GMK LABS, for FY 2025. Revenue was ₹20.38 Cr (-34% year on year). Net profit was ₹48.2 Lakh (2% margin). EBITDA was ₹1.39 Cr (7% margin). Revenue has grown at a compounded annual rate of -19% over three years and 0% over five years.

  • ₹20.38 CrRevenue · FY 2025 · -34% YoY
  • ₹48.2 LakhNet profit · 2% margin
  • ₹1.39 CrEBITDA · 7% margin
  • ₹1.66 CrPaid-up capital
  • 35Employees (provident fund records)
  • -19%Revenue CAGR, 3 years
  • 0%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Gmk Labs Private Limited are on its company page.

Premium access

Detailed financial statements for GMK LABS

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about GMK LABS

GMK LABS has 35 employees.

The primary company behind GMK LABS, Gmk Labs Private Limited, reported revenue of β‚Ή20.38 Cr for FY 2025, down 34% year on year.

GMK LABS Private Limited is noted for its dedication to excellence in the pharmaceutical industry, having been incorporated in 2006 to advance research and development of bulk drugs and intermediates. A culture of continuous learning and innovation is maintained, with processes and technologies regularly improved to stay ahead. Client needs are addressed through collaborative, tailored solutions that emphasize quality and trust, while customer and worker care is prioritized. This approach ensures high-quality products and long-term success are achieved in a fast-paced environment.

GMK LABS offers Bulk Drugs and Research Services.

GMK LABS operates through Gmk Labs Private Limited.

The legal entities of GMK LABS currently have 3 directors, including Murali Krishna Gollapudi, Nirmala Gollapudi, Gollapudi Sri Shanmukha Sri Krishna Chaitanya.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available